Adam Stern
Förmögenhet: 463 400 $ per 2026-06-30
Förmögenhet: 463 400 $ per 2026-06-30
Mr. Adam K.
Stern is an Independent Director at VivoSim Labs, Inc. and a Chief Executive Officer & Partner at SternAegis Ventures LLC.
He is on the Board of Directors at VivoSim Labs, Inc., DarioHealth Corp., Aerami Therapeutics Holdings, Inc. and Amplifica Holdings Group, Inc. (California).
Mr. Stern was previously employed as an Independent Director by Western Acquisition Ventures Corp., an Independent Director by OPKO Biologics Ltd., a Senior Managing Director by Spencer Trask Ventures, Inc., and a SVP & Managing Director-Private Equity Marketing by Josephthal, Lyon & Ross, Inc. He also served on the board at Applied Hydroponics, Inc, Aerami Therapeutics, Inc., Matinas BioPharma Holdings, Inc., LabStyle Innovations Corp., Design Source, Inc., Adgero Biopharmaceuticals Holdings, Inc., InVivo Therapeutics Corp.
and Prolor Biotech Ltd. He received his undergraduate degree from the University of South Florida.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
DARIOHEALTH CORP. 0,48 % | 2025-12-22 | 35 180 ( 0,48 % ) | 232 188 $ | 2026-06-30 |
| 2025-05-09 | 210 687 ( 1,54 % ) | 128 940 $ | 2026-06-30 | |
Zoomcar Holdings, Inc.
Zoomcar Holdings, Inc. Finance/Rental/LeasingFinance Operates carsharing platform 7,25 % | 2025-05-20 | 615 354 ( 7,25 % ) | 95 380 $ | 2026-06-30 |
VIVOSIM LABS INC 0,19 % | 2026-06-15 | 4 899 ( 0,19 % ) | 5 242 $ | 2026-06-30 |
DARIOHEALTH CORP PFCV C 1,44 % | 2025-09-11 | 250 ( 1,44 % ) | 1 650 $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| DARIOHEALTH CORP. | Direktör/Styrelseledamot | 2020-03-01 |
| VIVOSIM LABS, INC. | Direktör/Styrelseledamot | 2020-07-14 |
Aerami Therapeutics Holdings, Inc.
Aerami Therapeutics Holdings, Inc. Medical SpecialtiesHealth Technology Develops inhaled insulin devices | Direktör/Styrelseledamot | - |
SternAegis Ventures LLC
SternAegis Ventures LLC Investment ManagersFinance SternAegis Ventures invests in companies located in the United States. The firm focuses on broad range of sectors. It participates in early stage capital requirements. | Verkställande Direktör | 2012-11-01 |
Amplifica Holdings Group, Inc. (California)
Amplifica Holdings Group, Inc. (California) Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that is engaged is developing androgenic alopecia treatments | Direktör/Styrelseledamot | - |
| Företag | Position | Slut |
|---|---|---|
| CYCURION, INC. | Direktör/Styrelseledamot | 2023-12-28 |
| MATINAS BIOPHARMA HOLDINGS, INC. | Direktör/Styrelseledamot | 2020-11-02 |
| HYDROFARM HOLDINGS GROUP, INC. | Direktör/Styrelseledamot | 2020-01-01 |
| DARIOHEALTH CORP. | Direktör/Styrelseledamot | 2014-05-03 |
| ░░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 17 |
|---|---|
Augment Securities, Inc.
Augment Securities, Inc. Investment ManagersFinance Augment Securities invests in companies located in the United States. The firm focuses on a broad range of sectors. It participates in early stage capital requirements. | Finance |
OPKO Biologics Ltd.
OPKO Biologics Ltd. BiotechnologyHealth Technology Operates as a drug development company that develops bio-better long-acting therapeutic proteins | Health Technology |
VivoSim Labs, Inc.
VivoSim Labs, Inc. BiotechnologyHealth Technology Engages in developing and commercializing functional human tissues | Health Technology |
InVivo Therapeutics Corp.
InVivo Therapeutics Corp. BiotechnologyHealth Technology Develops groundbreaking technologies for the treatment of spinal cord injuries | Health Technology |
DarioHealth Corp.
DarioHealth Corp. Medical SpecialtiesHealth Technology Develops medical devices and mobile applications for self-monitoring of blood glucose | Health Technology |
Matinas BioPharma Holdings, Inc.
Matinas BioPharma Holdings, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Aerami Therapeutics Holdings, Inc.
Aerami Therapeutics Holdings, Inc. Medical SpecialtiesHealth Technology Develops inhaled insulin devices | Health Technology |
Josephthal & Co (Broker)
Josephthal & Co (Broker) Investment Banks/BrokersFinance Brokerage firm | Finance |
University of South Florida
University of South Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Invivo Therapeutics Holdings Corp.
Invivo Therapeutics Holdings Corp. BiotechnologyHealth Technology Develops technologies for the treatment of spinal cord injuries | Health Technology |
SternAegis Ventures LLC
SternAegis Ventures LLC Investment ManagersFinance SternAegis Ventures invests in companies located in the United States. The firm focuses on broad range of sectors. It participates in early stage capital requirements. | Finance |
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled insulin products to treat diabetes patients | Health Technology |
Adgero Biopharmaceuticals Holdings, Inc.
Adgero Biopharmaceuticals Holdings, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company focused on building a robust pipeline for oncology indications | Health Technology |
Prolor Biotech Ltd.
Prolor Biotech Ltd. BiotechnologyHealth Technology Develops proprietary versions of already-approved therapeutic proteins | Health Technology |
Hydrofarm Holdings Group, Inc.
Hydrofarm Holdings Group, Inc. Trucks/Construction/Farm MachineryProducer Manufacturing Manufactures and wholesales gardening equipment | Producer Manufacturing |
Western Acquisition Ventures Corp.
Western Acquisition Ventures Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Amplifica Holdings Group, Inc. (California)
Amplifica Holdings Group, Inc. (California) Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that is engaged is developing androgenic alopecia treatments | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån